KOR

e-Article

Ablation of bull prostate using novel bipolar radiofrequency ablation probe
Document Type
Report
Source
Journal of Endourology. Jan, 2009, Vol. 23 Issue 1, p11, 6 p.
Subject
United States
Language
English
ISSN
0892-7790
Abstract
Purpose: We describe the use of a novel bipolar radiofrequency (RF) system for the destruction of prostate tissue in an ex vivo model. Materials and Methods: A bipolar RF delivery system (Trod Medical, France) was linked to a 500 kHz generator. Eight lesions were created in an ex vivo bull prostate model using 7-mm (n = 4) and 10-mm probes (n = 4). Ablation was performed for 150 seconds. Temperature was recorded at the center of the lesion (Tc) and at the periphery (Tp) of the prostate. Tissue damage, both within and without the intended destruction zones, was assessed. The distance from Tc to Tp was recorded. Results: All lesions created with either the 7-mm or 10-mm bipolar RF ablation (RFA) probes demonstrated complete tissue destruction only within the intended zone. Using the 7-mm probe, the mean Tc was 82'C and the mean Tp 34[degrees]C. The mean distance from the edge of the lesion to the periphery was 5 mm. Impedance was 62 Ohm, and power was 4 watts during ablation with the 7-mm probe. With the 10-mm probe, the mean Tc and Tp were 70'C and 41[degrees]C, respectively. The mean distance from the edge of the lesion to the periphery was 5 mm. Impedance was 78 Ohm, and power was 4.5 watts during ablation with the 10-mm probe. Conclusions: In an ex vivo model, bipolar RFA is capable of producing lesions with precise margins. Spread of heat is limited, evidenced histologically and by significant temperature drop off. This technology holds promise in the management of benign and malignant urologic diseases.
Introduction RADIOFREQUENCY ABLATION (RFA) has been approved by the United States Food and Drug Administration for the management of soft tissue tumors. The role of RFA in the management of [...]